David R. Bauer
Lawyers
Filters
GH Research $117.5 million follow-on offering
We advised GH Research on the offering
Avalyn Pharma $300 million IPO
We advised the underwriters on the IPO
Revolution Medicines $2.2 billion common stock and convertible notes offerings
We advised the underwriters on the concurrent offerings
CytomX Therapeutics $250 million follow-on offering
We advised the representatives of the underwriters on the offering
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
AbbVie $8 billion senior notes offering
We advised the representatives of the underwriters on the offering
One Call acquisition of Data Dimensions
We are advising One Call on the transaction
Tandem Diabetes Care $300 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
TruArc Partners acquisition of Matrix Adhesives Group
We advised TruArc on the transaction
Revolution Medicines $1 billion at-the-market offering
We advised the sales agent on the offering